Last week, government published the second Life Sciences Sector Deal as part of their overarching Industrial Strategy. Headline announcements include: a £79 million new Accelerating Detection of Disease challenge in partnership with a number of charities to support the creation of cohort of 5 million healthy people for early diagnosis research; over £900m towards encouraging industry and collaborative R&D investment in the NHS; and five new centres for late-phase commercial research to be established. The Deal also outlined five guiding principles for commercial access to NHS data, one of which includes a commitment to research.

AMRC’s work on patient registries is included and the deal sets out the aim to explore the potential of patient registries, in collaboration with stakeholders including AMRC, with reference to our recent report - Saving lives with patient data registries. We’ll be taking this forward next year and looking at how we can ensure an environment for sharing and linking data that support patient registries. The sector deal follows on from the vision set out in last year’s Life Sciences Industrial Strategy and the first deal, which were published late last year.

DNA string

Back to e-newsletter